|
|
|
|
|
|
The latest drug discovery news from News Medical |
|
|
|
 | |
Autoimmune Disease Research Solutions
Sino Biological provides comprehensive solutions for autoimmune diseases, offering a wide range of research reagents for nearly 50 diseases. Our portfolio includes autoimmune disease target reagents such as target proteins, cytokines, and kinases, along with research reagents for biomarker studies.
| |
|
|
|
|
 | | Pharmacovigilance evolves with technology, employing active surveillance to detect drug-related issues and ensure safety in an increasingly complex landscape. | | | | Saccharin destabilizes bacterial membranes and interferes with DNA replication, causing lysis and impairing virulence traits. The sweetener also re-sensitizes multidrug-resistant pathogens to antibiotics and disrupts stubborn biofilms. | | | | Artificial intelligence offers breakthroughs in life sciences, yet issues of bias, interpretability, and ethics pose significant challenges to its adoption. | | | | GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach. | | | | Researchers used integrated Mendelian randomization in a cohort of over 247,000 individuals to identify 62 plasma proteins associated with breast cancer risk. Nine high-confidence targets, including ULK3 and CSK, showed potential for drug repurposing and immune pathway regulation. | |
|
|
|
|
 | | How would you rate today's newsletter?
| |
|
|
|
 | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|